Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide.
Ruszniewski P, Ish-Shalom S, Wymenga M, O'Toole D, Arnold R, Tomassetti P, Bax N, Caplin M, Eriksson B, Glaser B, Ducreux M, Lombard-Bohas C, de Herder WW, Delle Fave G, Reed N, Seitz JF, Van Cutsem E, Grossman A, Rougier P, Schmidt W, Wiedenmann B. Ruszniewski P, et al. Among authors: bax n. Neuroendocrinology. 2004;80(4):244-51. doi: 10.1159/000082875. Epub 2004 Dec 22. Neuroendocrinology. 2004. PMID: 15627802 Clinical Trial.
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A; UKNETwork for Neuroendocrine Tumours. Ramage JK, et al. Among authors: bax n. Gut. 2005 Jun;54 Suppl 4(Suppl 4):iv1-16. doi: 10.1136/gut.2004.053314. Gut. 2005. PMID: 15888809 Free PMC article. No abstract available.
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB; UK and Ireland Neuroendocrine Tumour Society. Ramage JK, et al. Among authors: bax n. Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3. Gut. 2012. PMID: 22052063 Free PMC article.
Octreotide therapy in carcinoid disease.
Bax ND, Woods HF, Batchelor A, Jennings M. Bax ND, et al. Anticancer Drugs. 1996 Jan;7 Suppl 1:17-22. doi: 10.1097/00001813-199601001-00004. Anticancer Drugs. 1996. PMID: 8822081 Review.
Clinical manifestations of carcinoid disease.
Bax ND, Woods HF, Batchelor A, Jennings M. Bax ND, et al. World J Surg. 1996 Feb;20(2):142-6. doi: 10.1007/s002689900022. World J Surg. 1996. PMID: 8661809 Review.
Abdominal carcinoid tumours in Sheffield.
Woods HF, Bax ND, Ainsworth I. Woods HF, et al. Among authors: bax nd. Digestion. 1990;45 Suppl 1:17-22. doi: 10.1159/000200256. Digestion. 1990. PMID: 2335266
Small bowel carcinoid tumors.
Woods HF, Bax ND, Smith JA. Woods HF, et al. Among authors: bax nd. World J Surg. 1985 Dec;9(6):921-9. doi: 10.1007/BF01655397. World J Surg. 1985. PMID: 4082614 No abstract available.
248 results